- Report
- March 2024
- 198 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- April 2024
- 93 Pages
Global
From €5414EUR$5,600USD£4,653GBP
- Report
- February 2024
- 112 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- March 2018
- 115 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Report
- August 2022
- 120 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- July 2023
- 91 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Report
- July 2023
- 90 Pages
Global
From €3500EUR$3,878USD£3,114GBP
- Report
- October 2023
- 146 Pages
Global
From €3410EUR$3,528USD£2,931GBP
€4012EUR$4,150USD£3,448GBP
- Report
- March 2023
- 132 Pages
Global
From €918EUR$950USD£789GBP
- Report
- February 2024
- 175 Pages
Global
From €3480EUR$3,600USD£2,991GBP
The Endoscopic Vessel Harvesting System (EVHS) market is a subset of the larger endoscopy market. EVHS is a minimally invasive procedure used to harvest vessels for coronary artery bypass grafting (CABG). It is a safe and effective alternative to traditional open-heart surgery, and is becoming increasingly popular due to its shorter recovery time and reduced risk of complications. EVHS systems typically include a console, a monitor, and a handpiece. The console is used to control the handpiece, which is used to cut and remove the vessels. The monitor displays the images of the vessels and allows the surgeon to accurately identify and harvest them.
Some of the major companies in the EVHS market include Medtronic, Stryker, and Terumo. Other companies include Cardiac Dimensions, CardioVascular Dynamics, and CardioMEMS. Show Less Read more